Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease neurofibromatosis
Comorbidity C0751690|malignant peripheral nerve sheath tumor
Sentences 19
PubMedID- 23161774 There are conflicting reports as to whether malignant peripheral nerve sheath tumor (mpnst) patients with neurofibromatosis type 1 (nf1) have worse prognosis than non-nf1 mpnst patients.
PubMedID- 23244685 Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.
PubMedID- 24166582 Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
PubMedID- 26018702 Foreign body abscess mimicking a malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1.
PubMedID- 23483452 We used genome-wide serum mirna expression analysis to investigate the role of serum mirnas in distinguishing malignant peripheral nerve sheath tumor (mpnst) patients with and without neurofibromatosis type 1 (nf1) from nf1 patients.
PubMedID- 20205747 malignant peripheral nerve sheath tumor associated with neurofibromatosis type 1, with metastasis to the heart: a case report.
PubMedID- 23292448 Since the bi-allelic inactivation of both neurofibromin 1 (nf1) gene alleles (nf1(-/-)) in schwann cells (scs) is common in both benign plexiform neurofibromas (pns) and malignant peripheral nerve sheath tumors (mpnsts) in patients with neurofibromatosis type 1 (nf1), other genetic alterations in scs may be required for tumor progression of pns to mpnsts.
PubMedID- 22869071 A novel nf1 mutation in a chinese patient with giant cafe-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality.
PubMedID- 25317349 malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1.
PubMedID- 22745048 Metronomic therapy for malignant peripheral nerve sheath tumor in neurofibromatosis type 1.
PubMedID- 23972085 Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review.
PubMedID- 23047517 Metastatic malignant peripheral nerve sheath tumor in neurofibromatosis type 1: a geriatric patient report.
PubMedID- 23242059 Purpose: the aim of this study was to compare the diagnostic performance of (1)(8)f-fluorodeoxyglucose (fdg) pet/ct and whole-body mri for the detection of malignant peripheral nerve sheath tumors (mpnsts) in patients with neurofibromatosis type 1, and to evaluate a panel of imaging-based criteria serving that purpose.
PubMedID- 21731277 Intraoral presentation of multiple malignant peripheral nerve sheath tumors associated with neurofibromatosis-1.
PubMedID- 23101443 Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.
PubMedID- 26445379 Diagnostic accuracy of pet/ct-guided percutaneous biopsies for malignant peripheral nerve sheath tumors in neurofibromatosis type 1 patients.
PubMedID- 20664435 Conclusion: neurofibromatosis type 1 with malignant peripheral nerve sheath tumors complicating pregnancy requires an experienced, multidisciplinary team of care offering an aggressive evaluation to rule out malignant transformation or recurrence when there is any change in clinical status of a patient, as this may signal a potentially fatal change in the lesion.
PubMedID- 20686424 The role of angiogenesis in the transformation of plexiform neurofibroma into malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1.
PubMedID- 24343189 malignant peripheral nerve sheath tumor in neurofibromatosis type 1.

Page: 1